Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Hoffmann-La Roche
Tianjin Medical University Cancer Institute and Hospital
Eastern Cooperative Oncology Group
Merck Sharp & Dohme LLC
Massachusetts General Hospital
Radiation Therapy Oncology Group
M.D. Anderson Cancer Center
Incyte Corporation
Insel Gruppe AG, University Hospital Bern
University of Kentucky
Sanford Health
Centre Antoine Lacassagne
EMD Serono
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Groupe Oncologie Radiotherapie Tete et Cou
Memorial Sloan Kettering Cancer Center
ALX Oncology Inc.
GERCOR - Multidisciplinary Oncology Cooperative Group
Merck Sharp & Dohme LLC
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
University of Pittsburgh
West China Hospital
Groupe Oncologie Radiotherapie Tete et Cou
Thomas Jefferson University
Beijing Tongren Hospital
University of Texas Southwestern Medical Center
Eurofarma Laboratorios S.A.
Biotech Pharmaceutical Co., Ltd.
Fudan University
City of Hope Medical Center
Institut du Cancer de Montpellier - Val d'Aurelle
Radiation Therapy Oncology Group
The Netherlands Cancer Institute
Beijing Tongren Hospital
Sun Yat-sen University
UNC Lineberger Comprehensive Cancer Center
Hunan Cancer Hospital
Washington University School of Medicine
EpicentRx, Inc.
UNC Lineberger Comprehensive Cancer Center
EpicentRx, Inc.
Institute of Oncology Ljubljana